FGF2-primed 3D spheroids producing IL-8 promote therapeutic angiogenesis in murine hindlimb ischemia
Abstract Peripheral artery disease is a progressive, devastating disease that leads to critical limb ischemia (CLI). Therapeutic angiogenesis using stem cell therapy has emerged as a promising approach for its treatment; however, adapting cell-based therapy has been limited by poor cell survival and...
Guardado en:
Autores principales: | , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/9f82ccb5f8b1426583a1c44e3d70a113 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:9f82ccb5f8b1426583a1c44e3d70a113 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:9f82ccb5f8b1426583a1c44e3d70a1132021-12-02T15:10:56ZFGF2-primed 3D spheroids producing IL-8 promote therapeutic angiogenesis in murine hindlimb ischemia10.1038/s41536-021-00159-72057-3995https://doaj.org/article/9f82ccb5f8b1426583a1c44e3d70a1132021-08-01T00:00:00Zhttps://doi.org/10.1038/s41536-021-00159-7https://doaj.org/toc/2057-3995Abstract Peripheral artery disease is a progressive, devastating disease that leads to critical limb ischemia (CLI). Therapeutic angiogenesis using stem cell therapy has emerged as a promising approach for its treatment; however, adapting cell-based therapy has been limited by poor cell survival and low treatment efficiency. To overcome unmet clinical needs, we developed a fibroblast growth factor 2 (FGF2)-immobilized matrix that enabled control of cell adhesion to the surface and exerted a priming effect on the cell. Human adipose-derived stem cells (hASCs) grown in this matrix formed a functionally enhanced cells spheroid (FECS-Ad) that secreted various angiogenic factors including interleukin-8 (IL-8). We demonstrated that IL-8 was upregulated by the FGF2-mediated priming effect during FECS-Ad formation. Immobilized FGF2 substrate induced stronger IL-8 expression than soluble FGF2 ligands, presumably through the FGFR1/JNK/NF-κB signaling cascade. In IL-8-silenced FECS-Ad, vascular endothelial growth factor (VEGF) expression was decreased and angiogenic potential was reduced. Intramuscular injection of FECS-Ad promoted angiogenesis and muscle regeneration in mouse ischemic tissue, while IL-8 silencing in FECS-Ad inhibited these effects. Taken together, our data demonstrate that IL-8 contributes to therapeutic angiogenesis and suggest that FECS-Ad generated using the MBP-FGF2 matrix might provide a reliable platform for developing therapeutic agents to treat CLI.Jungkyun ChoiWooshik ChoiYunji JooHaeun ChungDokyun KimSeung Ja OhSang-Heon KimNature PortfolioarticleMedicineRENnpj Regenerative Medicine, Vol 6, Iss 1, Pp 1-15 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Medicine R |
spellingShingle |
Medicine R Jungkyun Choi Wooshik Choi Yunji Joo Haeun Chung Dokyun Kim Seung Ja Oh Sang-Heon Kim FGF2-primed 3D spheroids producing IL-8 promote therapeutic angiogenesis in murine hindlimb ischemia |
description |
Abstract Peripheral artery disease is a progressive, devastating disease that leads to critical limb ischemia (CLI). Therapeutic angiogenesis using stem cell therapy has emerged as a promising approach for its treatment; however, adapting cell-based therapy has been limited by poor cell survival and low treatment efficiency. To overcome unmet clinical needs, we developed a fibroblast growth factor 2 (FGF2)-immobilized matrix that enabled control of cell adhesion to the surface and exerted a priming effect on the cell. Human adipose-derived stem cells (hASCs) grown in this matrix formed a functionally enhanced cells spheroid (FECS-Ad) that secreted various angiogenic factors including interleukin-8 (IL-8). We demonstrated that IL-8 was upregulated by the FGF2-mediated priming effect during FECS-Ad formation. Immobilized FGF2 substrate induced stronger IL-8 expression than soluble FGF2 ligands, presumably through the FGFR1/JNK/NF-κB signaling cascade. In IL-8-silenced FECS-Ad, vascular endothelial growth factor (VEGF) expression was decreased and angiogenic potential was reduced. Intramuscular injection of FECS-Ad promoted angiogenesis and muscle regeneration in mouse ischemic tissue, while IL-8 silencing in FECS-Ad inhibited these effects. Taken together, our data demonstrate that IL-8 contributes to therapeutic angiogenesis and suggest that FECS-Ad generated using the MBP-FGF2 matrix might provide a reliable platform for developing therapeutic agents to treat CLI. |
format |
article |
author |
Jungkyun Choi Wooshik Choi Yunji Joo Haeun Chung Dokyun Kim Seung Ja Oh Sang-Heon Kim |
author_facet |
Jungkyun Choi Wooshik Choi Yunji Joo Haeun Chung Dokyun Kim Seung Ja Oh Sang-Heon Kim |
author_sort |
Jungkyun Choi |
title |
FGF2-primed 3D spheroids producing IL-8 promote therapeutic angiogenesis in murine hindlimb ischemia |
title_short |
FGF2-primed 3D spheroids producing IL-8 promote therapeutic angiogenesis in murine hindlimb ischemia |
title_full |
FGF2-primed 3D spheroids producing IL-8 promote therapeutic angiogenesis in murine hindlimb ischemia |
title_fullStr |
FGF2-primed 3D spheroids producing IL-8 promote therapeutic angiogenesis in murine hindlimb ischemia |
title_full_unstemmed |
FGF2-primed 3D spheroids producing IL-8 promote therapeutic angiogenesis in murine hindlimb ischemia |
title_sort |
fgf2-primed 3d spheroids producing il-8 promote therapeutic angiogenesis in murine hindlimb ischemia |
publisher |
Nature Portfolio |
publishDate |
2021 |
url |
https://doaj.org/article/9f82ccb5f8b1426583a1c44e3d70a113 |
work_keys_str_mv |
AT jungkyunchoi fgf2primed3dspheroidsproducingil8promotetherapeuticangiogenesisinmurinehindlimbischemia AT wooshikchoi fgf2primed3dspheroidsproducingil8promotetherapeuticangiogenesisinmurinehindlimbischemia AT yunjijoo fgf2primed3dspheroidsproducingil8promotetherapeuticangiogenesisinmurinehindlimbischemia AT haeunchung fgf2primed3dspheroidsproducingil8promotetherapeuticangiogenesisinmurinehindlimbischemia AT dokyunkim fgf2primed3dspheroidsproducingil8promotetherapeuticangiogenesisinmurinehindlimbischemia AT seungjaoh fgf2primed3dspheroidsproducingil8promotetherapeuticangiogenesisinmurinehindlimbischemia AT sangheonkim fgf2primed3dspheroidsproducingil8promotetherapeuticangiogenesisinmurinehindlimbischemia |
_version_ |
1718387648801800192 |